Additionally, tumor tissue analysis revealed a significant decrease in ICAM1, MMP9 and MUC1 expression following atorvastatin treatment (Fig. 6G and Figure S8A), along with inhibited MAPK pathway activation (Fig. 6H and Figure S8B). The gene discussed is MUC1; the disease is neoplasm.